Japan· JP-2290705G1029
フルチカゾンフランカルボン酸エステル
A fluticasone product containing フルチカゾンフランカルボン酸エステル, registered in Japan by グラクソ・スミスクライン, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Fluticasone is registered in 10 of 19 countries.
Countries holding a registration under ATC D07AC17 (fluticasone), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 7 of them publish a price we can compare per daily dose
Fluticasone · ATC D07AC17
10 / 19 countries
- Belgiumprice
- Finlandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- フルチカゾンフランカルボン酸エステル
- Manufacturer
- グラクソ・スミスクライン
- Country
- Japan (JP)
- ATC code
- D07AC17
- ATC class
- Fluticasone
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
56 interactions on record for fluticasone.
Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fluticasone · interactions on record
56 records
- 1 moderate
- 55 minor
Most severe, free to view
- EchinaceaD03AH02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fluticasone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United States24 Hour Allergy NasalWalgreen Company
- United KingdomAvamys 27.5micrograms/dose nasal sprayMawdsley-Brooks & Company Ltd
- FinlandAvamysParanova Oy
- SpainAVAMYS 27,5 mcg/PULVERIZACION PARA SUSPENSION NASALGlaxo Group Limited
- BelgiumAerivio Spiromax 50 µg - 500 µgTeva
- NetherlandsCortifil 0,5 mg/g crèmeLaboratorios SALVAT, S.A.
- CzechiaAVAMYSGlaxoSmithKline Trading Services Limited, Dublin
- PolandAvamysGlaxoSmithKline (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Flixonase Aquosum, Flixotide Diskus Forte
- Belgium · Flixonase Aqua, Flixotide
- Bulgaria · Аркуист, Фликсоназе
- Cyprus · Cutivate, Flixonase Aqueous
- Czechia · Flixotide Diskus, Flixotide Inhaler N
- Germany · Flutica, Fluticason Cipla
- Denmark · Flixotide, Flurhin
- Estonia · Cutivate Cream, Flixonase
- Spain · Avancort, Flixonase
- Finland · Flixonase, Flixotide Diskus
- France · Fixorinox, Flixonase
- United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
- Greece · Alerxem, Bocacort-S
- Croatia · Flixonase, Flixotide Inhaler
- Hungary · Cutivate, Flixonase
- Ireland · Arquist, Flixonase Allergy Relief
- Iceland · Avamys, Flixotide
- Italy · Aktanos, Deflut
- Liechtenstein · Avamys
- Lithuania · Cutivate, Flixotide
- Luxembourg · Flixonase Aqua, Flixotide
- Latvia · Flixonase, Flixotide
- Malta · Cutivate, Flihaler
- Netherlands · Cortifil, Cutivate
- Norway · Avamys, Flurhin
- Poland · Cutivate, Fanipos
- Portugal · Brisovent Diskus, Brisovent Inalador
- Romania · Arquist, Cutivate
- Sweden · Arquist, Fluticasone Cipla
- Slovenia · Flixonase, Flixotide
- Slovakia · Flixonase Aqueous, Flixotide Diskus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3d504ed-220c-45b6-9684-35be4d11e428 GET /v1/drugs/b3d504ed-220c-45b6-9684-35be4d11e428?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "30吸入1キット",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2290705G1029",
"category": "外用薬",
"price_yen": 1090.5,
"generic_name": "フルチカゾンフランカルボン酸エステル",
"product_name_jp": null,
"therapeutic_class": "2290",
"transitional_expiry": null
}See everything about fluticasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.